Login / Signup

Development of a Multivariable Model to Predict the Need for Bone Marrow Sampling in Persons With Monoclonal Gammopathy of Undetermined Significance : A Cohort Study Nested in a Clinical Trial.

Elias EythorssonSaemundur RognvaldssonSigrún ÞorsteinsdóttirThorir Einarsson LongElin Ruth ReedGudrun Asta SigurdardottirBrynjar VidarssonPall Torfi OnundarsonBjarni A AgnarssonMargret SigurdardottirIsleifur OlafssonIngunn ThorsteinsdottirSigny Vala SveinsdottirFridbjorn SigurdssonAsdis Rosa ThordardottirRunolfur PalssonOlafur Skuli IndridasonAsbjorn JonssonGauti Kjartan GíslasonAndri OlafssonJon SigurdssonHlif SteingrimsdottirMalin L HultcrantzBrian G M DurieStephen HardingCarl Ola LandgrenThor AspelundThorvardur Jon LoveSigurður Yngvi Kristinsson
Published in: Annals of internal medicine (2024)
International Myeloma Foundation and the European Research Council.
Keyphrases
  • bone marrow
  • clinical trial
  • multiple myeloma
  • mesenchymal stem cells
  • phase ii
  • open label
  • study protocol
  • double blind
  • newly diagnosed
  • randomized controlled trial
  • case control
  • phase iii